Genflow Signs CDAs with Animal Health Companies

Core Insights - Genflow Biosciences Plc has signed two Confidential Disclosure Agreements (CDAs) with leading animal health companies to facilitate data exchange and discussions on potential collaborations [1] Company Strategy - The signing of the CDAs represents a significant milestone in Genflow's strategy to utilize its proprietary SIRT6-centenarian gene therapy platform for applications in both human and animal health [1]